AB Artiva Biotherapeutics, Inc. Stock: price and management transactions · United States · SEC (Form 4)Source id SEC:artiva-biotherapeutics-inc-04d548 US · SEC (Form 4) Mcap US$542.2M Follow the Artiva Biotherapeutics, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €542.2m. The latest transaction was reported on 11 September 2026 (Attribution). Among the most active insiders: RA CAPITAL MANAGEMENT, L.P.. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 September 2026
All Executives78 Thresholds0 Prospectus0 Other0
Declarations 78 total
◆ Chief Medical Officer · Executives · 9 Sept 2026
30,000 shares 0Common Stock SEC:0001193125-26-389510:0
◆ COO, CLO, Compliance Officer · Executives · 9 Sept 2026
45,000 shares 0Common Stock SEC:0001193125-26-389511:0
◆ Chief Tech Operations Officer · Executives · 9 Sept 2026
40,000 shares 0Common Stock SEC:0001193125-26-389512:0
◆ President & Head of R&D · Executives · 9 Sept 2026
45,000 shares 0Common Stock SEC:0001193125-26-389514:0
▼ Chief Executive Officer · Executives · 8 Sept 2026
23,429 shares @ US$10.9158 0.047% mcap 22.2% of flow Common Stock SEC:0001193125-26-386431:0
● Director, Officer · Executives · 8 Sept 2026
23,429 shares @ US$11.19 0.048% mcap 100.0% of flow Common SEC144:0001950047-26-009217
▼ Chief Executive Officer · Executives · 3 Sept 2026
61,888 shares @ US$11.1555 0.13% mcap 77.5% of flow Common Stock SEC:0001193125-26-383618:0
▼ Chief Medical Officer · Executives · 3 Sept 2026
1,100 shares @ US$11.1556 0.0023% mcap 9.7% of flow Common Stock SEC:0001193125-26-383619:0
▼ COO, CLO, Compliance Officer · Executives · 3 Sept 2026
8,391 shares @ US$11.1555 0.017% mcap 86.9% of flow Common Stock SEC:0001193125-26-383621:0
▼ Chief Tech Operations Officer · Executives · 3 Sept 2026
10,366 shares @ US$11.1555 0.021% mcap 92.7% of flow Common Stock SEC:0001193125-26-383625:0
◇ Chief Medical Officer · Executives · 27 Aug 2026
5,306 shares @ US$1.92 0.0019% mcap 8.9% of flow Common Stock SEC:0001193125-26-377207:0
▼ Chief Medical Officer · Executives · 27 Aug 2026
8,222 shares @ US$12.0087 0.018% mcap 85.9% of flow Common Stock SEC:0001193125-26-377207:1
● Officer · Executives · 27 Aug 2026
7,818 shares @ US$11.77 0.016% mcap 90.3% of flow Common SEC144:0001950047-26-008761
◇ Chief Medical Officer · Executives · 18 Aug 2026
429 shares @ US$1.92 0.0001% mcap 13.8% of flow Common Stock SEC:0001193125-26-357383:0
▼ Chief Medical Officer · Executives · 18 Aug 2026
429 shares @ US$12.00 0.0009% mcap 86.2% of flow Common Stock SEC:0001193125-26-357383:1
● Officer · Executives · 18 Aug 2026
833 shares @ US$11.74 0.0017% mcap 100.0% of flow Common SEC144:0001950047-26-008347
▲ Director · Executives · 31 Jul 2026
24,944 shares @ US$9.93 0.051% mcap 4.8% of flow Common Stock SEC:0001231919-26-000817:1
Canonical exit: 29 Oct 2026 (T+90) ▲ Director · Executives · 29 Jul 2026
20,824 shares @ US$9.99 0.043% mcap 4.1% of flow Common Stock SEC:0001231919-26-000817:0
Canonical exit: 27 Oct 2026 (T+90) ▲ Director · Executives · 24 Jul 2026
41,319 shares @ US$9.99 0.085% mcap 8.9% of flow Common Stock SEC:0001231919-26-000808:0
Canonical exit: 22 Oct 2026 (T+90) ▲ Director · Executives · 23 Jul 2026
59,880 shares @ US$9.96 0.12% mcap 14.0% of flow Common Stock SEC:0001231919-26-000791:2
Canonical exit: 21 Oct 2026 (T+90) ▲ Director · Executives · 21 Jul 2026
120,582 shares @ US$9.55 0.24% mcap 27.0% of flow Common Stock SEC:0001231919-26-000791:0
Canonical exit: 19 Oct 2026 (T+90) ▲ Director · Executives · 22 Jul 2026
84,124 shares @ US$9.93 0.17% mcap 19.6% of flow Common Stock SEC:0001231919-26-000791:1
Canonical exit: 20 Oct 2026 (T+90) ▲ Director · Executives · 13 Jul 2026
6,522 shares @ US$8.94 0.012% mcap 1.4% of flow Common Stock SEC:0001231919-26-000790:0
Canonical exit: 11 Oct 2026 (T+90) ▲ Director · Executives · 16 Jul 2026
152,472 shares @ US$8.93 0.29% mcap 83.7% of flow Common Stock SEC:0001231919-26-000774:0
Canonical exit: 14 Oct 2026 (T+90) ▲ Director · Executives · 17 Jul 2026
7,882 shares @ US$8.95 0.015% mcap 4.3% of flow Common Stock SEC:0001231919-26-000774:1
Canonical exit: 15 Oct 2026 (T+90) 25 of 78 declarations
Load more (53 remaining) 关于 Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. 是一家生物制药公司，专注于开发癌症治疗的细胞疗法。它利用创新技术改善患者预后。